Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1997. Start Trial.
Date Value
December 31, 2025 939.65M
December 31, 2024 1.355B
December 31, 2023 1.676B
December 31, 2022 1.989B
December 31, 2021 2.116B
December 31, 2020 1.939B
December 31, 2019 1.125B
December 31, 2018 1.174B
December 31, 2017 1.079B
December 31, 2016 328.54M
December 31, 2015 203.19M
December 31, 2014 210.34M
December 31, 2013 264.22M
December 31, 2012 187.66M
December 31, 2011 39.90M
Date Value
December 31, 2010 33.59M
December 31, 2009 48.73M
December 31, 2008 11.76M
December 31, 2007 25.36M
December 31, 2006 33.31M
December 31, 2005 47.05M
December 31, 2004 19.52M
December 31, 2003 37.60M
December 31, 2002 19.29M
December 31, 2001 25.60M
December 31, 2000 32.11M
December 31, 1999 11.62M
December 31, 1998 8.51M
December 31, 1997 17.64M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Moderna, Inc. 5.80B
Arrowhead Pharmaceuticals, Inc. 919.37M
ImmunityBio, Inc. 242.82M
X4 Pharmaceuticals, Inc. 253.80M
MapLight Therapeutics, Inc. 305.10M